Search

Your search keyword '"D'Amato D"' showing total 744 results

Search Constraints

Start Over You searched for: Author "D'Amato D" Remove constraint Author: "D'Amato D"
744 results on '"D'Amato D"'

Search Results

3. T.05.4: RENAL LITHOGENIC RISK IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES CORRELATES WITH MICROBIOTA COMPOSITION, URINARY PROFILE AND DIETARY INTAKE

7. P442 Renal lithogenic risk in patients with Inflammatory Bowel Diseases correlates with microbiota composition, urinary profile and dietary intake

13. Metric Learning in Histopathological Image Classification: Opening the Black Box

18. Magnetic Resonance-based fibrosis markers in patients with Non-Alcoholic Fatty Liver Disease: Exploratory data from the Turin cohort

19. A nutrigenetic precision approach for the management of NAFLD

22. T.07.3 PROGNOSTIC VALUE OF LIVER STIFFNESS AND FIB-4 SCORE IN INDIVIDUALS WITH CIRRHOSIS DUE TO NON-ALCOHOLIC FATTY LIVER DISEASE WITHOUT PREVIOUS LIVER DECOMPENSATION

23. Long-term results from the Italian real-world experience on obeticholic acid treatment in primary biliary cholangitis: The RECAPITULATE study

24. Social jetlag and mediterranean diet adherence are associated to liver fibrosis in patients with non-alcoholic fatty liver disease

25. Echocardiography-based markers of subclinical cardiac dysfunction in individuals with Non-Alcoholic Fatty Liver Disease and preserved ejection fraction: Interim data from a prospective study

26. Prognostic value of simple non-invasive tests for the risk stratification of hcc development in patients with cirrhosis due to non-alcoholic fatty liver disease

27. Prediction of response to obeticholic acid in primary biliary cholangitis: Development and validation of the OCA response score (ORS)

30. A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis

32. Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid

33. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055))

35. On the prediction of keyholes by propagation of the MOID

36. PC.01.8 RADIOMICS-BASED MODEL FOR OUTCOME PREDICTION IN PRIMARY SCLEROSING CHOLANGITIS

37. Effects of dopamine on leptin release and leptin gene (OB) expression in adipocytes from obese and hypertensive patients

38. The Reuven Ramaty High-Energy Solar Spectroscopic Imager (Rhessi)

39. Enforcing state constraints in dynamical systems modelled with neural networks

40. Spectral analysis of US Space Catalog ephemerides for LAGEOS-1

42. Technology for NASA's Planetary Science Vision 2050.

43. Radiomics-based model for outcome prediction in primary sclerosing cholangitis

44. Predictors of Serious Adverse Event and Non-response in Cirrhotic Patients With Primary Biliary Cholangitis under Obeticholic Acid

47. Frequency domain analysis of the mean and osculating trajectories of LAGEOS-1

Catalog

Books, media, physical & digital resources